BTG plc (LON:BTG – Get Free Report) shares crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 840 ($10.63) and traded as high as GBX 840 ($10.63). BTG shares last traded at GBX 840 ($10.63), with a volume of 271,742 shares changing hands.
BTG Stock Performance
The business’s fifty day simple moving average is GBX 840 and its 200-day simple moving average is GBX 840. The firm has a market capitalization of £3.26 billion and a PE ratio of 29.47.
BTG Company Profile
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Further Reading
- Five stocks we like better than BTG
- ETF Screener: Uses and Step-by-Step Guide
- You Can Follow BlackRock’s Market View for Your Money
- Where Do I Find 52-Week Highs and Lows?
- Breakout Alert: Coinbase’s Consolidation Is About To End
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Key Stocks Helping to Drive the EV Race
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.